Picture of Strides Pharma Science logo

STAR — Strides Pharma Science News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Strides Pharma Science Says Stelis Biopharma's CDMO Partner Gets Approval For Key ANDA From USFDA

Dec 28 (Reuters) - Strides Pharma Science Ltd  SRID.NS :
    * STRIDES PHARMA SCIENCE LTD - STELIS BIOPHARMA'S CDMO PARTNER RECEIVES APPROVAL FOR A KEY
ANDA
FROM USFDA

Source text for Eikon:  ID:nBSE2VgM12 
Further company coverage:  SRID.NS 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Strides Pharma Science

See all news